Connect with us

Media OutReach

Hong Kong Genome Institute and Global Leaders Co-organise Landmark Healthcare Event “International Genomic Medicine Symposium”

Published

on

Convening Experts to Promote Hong Kong and Advance Medical Innovation

HONG KONG SAR – Media OutReach Newswire – 25 June 2025 – Genomic medicine is one of the most promising fields in today’s healthcare landscape, enabling precise diagnoses, personalised treatment plans, and breakthroughs in drug development that bring new hope to patients around the world. The Hong Kong Genome Institute (HKGI) will join forces with world-renowned authorities to host the International Genomic Medicine Symposium (Symposium) on 17 November 2025 (Monday). This landmark event will highlight Hong Kong’s unique strengths in fostering exchange and cooperation with experts worldwide in medical research and innovation, and accelerate the application of genomic medicine to pave the way for a healthier future for all.

The Symposium marks HKGI’s first collaboration with Rare Diseases International (RDI) and The Lancet Commission on Rare Diseases (LCRD), which is jointly led by RDI and The Lancet, the world’s most influential medical journal. The event will welcome local and international genomics leaders from over 20 countries and regions, including clinicians, scientists, and researchers from Mainland China, Europe, North and South America, and Australia.

Distinguished speakers at the Symposium will focus on key global topics such as clinical genetics, rare diseases, genomic medicine, AI, data sharing, as well as ethical and legal matters involved, facilitating in-depth discussions on the latest groundbreaking research and clinical insights. Specifically, thematic sessions will be dedicated to experience sharing by experts from Mainland China and Hong Kong. By showcasing case studies from the Hong Kong Genome Project, these exchanges will help demonstrate practical applications of personalised medicine in managing common disorders such as cardiomyopathy and kidney disease. Developments in rare diseases in Mainland China and drug development opportunities in the Guangdong-Hong Kong-Macao Greater Bay Area will also be covered, opening doors of opportunity for regional collaboration and innovation.

Dr Lo Su-vui, Chief Executive Officer of HKGI said, “With the strong support from the Health Bureau of the Hong Kong SAR Government, HKGI has been working closely with the Department of Health, Hospital Authority, medical schools of local universities and various stakeholders to accelerate the development of genomic medicine in Hong Kong. In just a few years, the Institute has achieved significant milestones in medical research, clinical applications, and international collaborations. We have successfully recruited over 47,000 participants for the Hong Kong Genome Project, continuously expanding our genome database featuring the Southern Chinese population. We have also accumulated clinical application cases and established synergistic collaborative research platforms. These achievements highlight Hong Kong’s strong capabilities and advantages in genomic medicine, laying a solid foundation for further collaboration with internationally recognised authorities.”

Dr Lo continued, “We are greatly honoured to partner with RDI and LCRD to organise this prestigious global event. Genomic medicine is the future of medicine with wide-ranging applications, spanning from common to rare diseases, from clinical diagnosis and personalised treatment to disease prevention and health management. This Symposium will undoubtedly serve as a critical platform for healthcare experts, academics, and researchers from around the world to exchange knowledge, fostering collaboration, and driving medical innovation, ultimately bringing immense benefits to patients in Hong Kong, Asia and beyond.”

The one-day Symposium is expected to attract nearly 300 industry professionals. Following the Symposium, the LCRD will hold its annual meeting in Hong Kong on 18-19 November to further discuss insights and deepen cross-regional collaboration. This will be the first time for the LCRD to host its annual meeting in Asia, highlighting Hong Kong’s distinctive position in leading international medical innovation.

For information about the Symposium programme and speakers, please refer to the appendix. For enquiries about the Symposium, please contact HKGI (sy*******@**********rg.hk) or RDI-LCRD (lc**@*************nt.org).

Rundown
International Genomic Medicine Symposium

17 November 2025, Hong Kong

Charles K. Kao Auditorium, Hong Kong Science Park

Time Programme Speaker
09:00 Keynote Prof Lo Chung-mau, BBS, JP
Secretary for Health
Hong Kong SAR Government,
Hong Kong, China
09:15 Opening Ceremony
Panel 1 Session Chairperson: Dr Ronald Lam, JP
Director of Health
Hong Kong SAR Government,
Hong Kong, China
09:30 Developing Rare Disease Models in China: Service, Teaching and Research Prof Zhang Shuyang
President
Peking Union Medical College Hospital, China
10:00 Unraveling Molecular Pathogeneses to Enhance Patient Care and Family Well-being Prof Kym Boycott
Co-Chair
Lancet Commission on Rare Diseases
Professor of Pediatrics
University of Ottawa, Canada
10:30 Panel Discussion
Panel 2 Session Chairperson: Dr Libby Lee, JP
Under Secretary for Health
Hong Kong SAR Government,
Hong Kong, China
11:15 Insights into Rare Diseases:
Focus on Inborn Errors of Metabolism
Prof Roberto Giugliani
Co-Chair
Lancet Commission on Rare Diseases
Professor of Genetics
Federal University of Rio Grande do Sul, Brazil
11:45 Hong Kong Genome Project Case Sharing (1) – Unlocking the Genomics of Cardiomyopathy: A New Era in Heart Health Dr Derek Lee
Hong Kong College of Physicians –
Hong Kong Genome Institute Scholar
Hong Kong, China
12:00 Hong Kong Genome Project Case Sharing (2) – Precision Medicine in Nephrology Dr Becky Ma
Hong Kong Academy of Medicine –
Hong Kong Genome Institute Scholar
Hong Kong, China
12:15 Panel Discussion
12:30 Lunch
Panel 3 Session Chairperson: Prof Philip Chiu
Dean of Medicine
The Chinese University of Hong Kong,
Hong Kong, China
14:00 Revolutionising Plasma DNA Analysis in Transforming Non-invasive Testing and Cancer Detection Prof Dennis Lo, SBS, JP
Vice-Chancellor and President
The Chinese University of Hong Kong
Board Member
Hong Kong Genome Institute
Hong Kong, China
14:30 Publishing at The Lancet Dr Chloe Wilson
Senior Medical Editor
The Lancet
15:00 Panel Discussion
Panel 4 Session Chairperson: Prof Lau Chak-sing, BBS, JP
Vice-President & Pro-Vice-Chancellor (Health)
Dean of Medicine
The University of Hong Kong
Board Member
Hong Kong Genome Institute
Hong Kong, China
15:35 AI in Action:
The Journey from Clinical Record to Personalised Treatment
Prof Gareth Baynam
Medical Director
Rare Care Centre
Perth Children’s Hospital, Australia
16:05 Harnessing the Power of Electronic Healthcare Records in Scientific Research and Innovation in Genomic Medicine Prof Yong Chen
Professor of Biostatistics
University of Pennsylvania, USA
16:35 Panel Discussion
Panel 5 Session Chairperson: To be confirmed
16:50 The Health Rights of Children and Genomic Newborn Screening Prof Bartha Knoppers
Director
Centre of Genomics and Policy
McGill University, Canada
17:20 Hong Kong Genome Project:
Advancing the Genomics Frontier
Dr Brian Chung
Chief Medical and Scientific Officer
Hong Kong Genome Institute,
Hong Kong, China
17:40 Genomics as a Catalyst for
Drug Development in the Greater Bay Area
Prof Aya El Helali
Clinical Assistant Professor
Department of Clinical Oncology,
School of Clinical Medicine,
The Li Ka Shing Faculty of Medicine of the University of Hong Kong,
Hong Kong, China
18:00 Panel Discussion
18:15 End of Symposium

(Last updated on 25 June 2025)


Enquiry
Hong Kong Genome Institute
Website: www.hkgp.org
Email: sy*******@**********rg.hk

Rare Disease International
Website: www.rarediseasesinternational.org
Email: lc**@*************nt.org

Hashtag: #HongKongGenomeInstitute

The issuer is solely responsible for the content of this announcement.

About Hong Kong Genome Institute

The Hong Kong Genome Institute (HKGI), established and wholly owned by the Hong Kong SAR Government, commenced full operations in 2021. With the vision “to avail genomic medicine to all for better health and well-being” and supported by the Health Bureau, HKGI works in close collaboration with the Department of Health, Hospital Authority, medical schools of local universities and other stakeholders to accelerate the development of genomic medicine in Hong Kong along four strategic foci: integrate genomics into medicine, advance research, nurture talents and enhance public genomic literacy.

As the first step towards achieving its vision, HKGI launched the Hong Kong Genome Project (HKGP) in 2021 focusing on diseases and research cohorts that would benefit from whole genome sequencing. They include undiagnosed diseases, hereditary cancers and cases related to genomics and precision health. Being the city’s first large-scale genome sequencing project, HKGP serves as a catalyst to benefit patients and their families with more precise diagnosis and personalised treatment. It also aims to establish genome database of the local population, testing infrastructure and talent pool to address the healthcare needs of Hong Kong in the long run.

For more information, please visit .

About Rare Diseases International
Rare Diseases International (RDI) is the global alliance of people living with a rare disease of all nationalities across all rare diseases. RDI’s mission is to be a strong common voice on behalf of rare disease patients around the world, to advocate for rare diseases as an international public health priority and to represent its members and enhance their capacities. RDI has more than 120 member organizations from 50 countries, which in turn represent rare disease patient groups in more than 150 countries worldwide.

For more information, please visit .

About Lancet Commission on Rare Diseases
The RDI-Lancet Commission on Rare Diseases (RDI-LCRD) is a new initiative dedicated to improving the lives of Persons Living with a Rare Disease (PLWRD) globally by generating evidence-informed recommendations that can be implemented in all countries. The RDI-LCRD, chaired by Dr Roberto Giugliani (Brazil) and Dr Kym Boycott (Canada) brings together 27 Commissioners from 6 continents with a broad range of expertise, perspectives and experience. The overarching goal of the RDI-LCRD is to use robust data to ignite global action that will amplify the voices of PLWRD and ensure that they are seen, heard, and cared for, no matter where they live.

For more information, please visit .

Media OutReach

Blackwall Enters Vietnam: European Web Traffic Security Firm Launches Southeast Asia Expansion with 19-Year Hosting Partner HostVN

Published

on

Estonian web traffic security company Blackwall announces its first publicly disclosed Southeast Asia partnership, bringing integrated traffic security to Vietnam’s digital infrastructure market through HostVN

HANOI, VIETNAM – Media OutReach Newswire – 23 June 2026 – Blackwall, a European web traffic security company, today announced a partnership with HOSTVN TECHNOLOGY SOLUTIONS JOINT STOCK COMPANY (HostVN), Vietnam’s established digital infrastructure provider, to launch HOSTVN Website Protection – powered by Blackwall. The partnership marks Blackwall’s first publicly announced entry into Southeast Asia.

Mr. Madan Rai (Blackwall) and Mr. Vuong Duy Nam(HostVN) sign the MOU formalising Blackwall’s first publicly announced Southeast Asia partnership, bringing enterprise-grade web traffic protection to Vietnam’s digital business community.

Under the agreement, HostVN integrates Blackwall’s all-in-one traffic security platform into its hosting infrastructure, offering Vietnamese businesses integrated website protection covering L7 DDoS defence, advanced bot mitigation, web application firewall (WAF), SSL management, and content caching, delivered seamlessly by HostVN, requiring no in-house security expertise from the customer.

A New Category: Traffic Quality as a Business Problem

The partnership addresses a challenge that most Vietnamese businesses have not yet named: according to Statista Research, more than half of all web traffic today is generated by automated bots and not human visitors. The consequences extend beyond traditional security risks into hidden operational costs, skewed business intelligence, and revenue leakage.

“Vietnam is ready, and Blackwall is committing to it,” said Madan Rai, VP Sales Asia at Blackwall. “More than half the traffic hitting a website today is not a real customer. Bots and automated requests consume bandwidth, distort analytics, and drain advertising spend — silently, every day. Through HostVN, we are placing enterprise-grade traffic security directly into the infrastructure that Vietnamese businesses already rely on. This partnership anchors Blackwall’s broader expansion across Southeast Asia. We chose Vietnam as our launchpad because its digital economy is scaling rapidly, and it requires infrastructure that matches that ambition.”

HostVN: 19 Years, Six Reinventions

Founded in 2007, HostVN has served Vietnamese businesses across five successive phases of the digital economy: from web hosting to cloud infrastructure, content delivery, digital transformation services, and AI-related offerings. The Blackwall partnership represents the company’s sixth strategic evolution, adding intelligent traffic security to its infrastructure stack.

“Nineteen years ago, we started HostVN with one purpose: to give Vietnamese businesses a strong foundation on the internet,” said Duong Thanh Binh, Chairman of HostVN. “Vietnam has not stood still, and neither have we. Every phase of our growth has been driven by the same commitment – to give the businesses that trust us the infrastructure they need to thrive. Today, the threat is not just downtime. It is invisible traffic that costs money, corrupts data, and goes undetected. HOSTVN Website Protection, powered by Blackwall, is our answer and our commitment to Vietnam’s digital future.”

Technology Built for Service Providers Partners

Blackwall operates on a channel-first model. Its traffic security platform is designed to be delivered exclusively through hosting and cloud infrastructure providers. This model gives partners full control over pricing and packaging, while allowing them to retain the direct customer relationship.

The Blackwall platform operates as a reverse proxy positioned in front of customer websites. Traffic is inspected across multiple detection layers, including Layer 4 and Layer 7 signature analysis, comprehensive device fingerprinting, IP reputation scoring, and proprietary behavioural algorithms. Clean traffic is then forwarded to the origin server and malicious requests are blocked or presented controlled responses. The process is transparent to legitimate users, with no added latency.

HOSTVN Website Protection delivers this capability across four integrated components:

  • L7 DDoS Protection: application-layer attack mitigation running on HostVN’s Clean Traffic infrastructure
  • Advanced Bot Mitigation: Real-time detection and classification of humans, trusted bots, and automated traffic, including AI agents, to identify benign and malicious activity. Web Application Firewall (WAF): OWASP Top 10 aligned protection against injection attacks, cross-site scripting, and common web exploits
  • SSL Management and Content Caching: automated SSL certificate handling, encrypted delivery, and performance optimisation that reduces server load and improves page speed

Vietnam as Blackwall’s First Southeast Asia Launch Market

Vietnam’s digital economy has grown substantially over the past decade, with business online presence now standard across sectors. Alongside that growth, the volume of automated and malicious web traffic targeting Vietnamese sites has increased in proportion. HostVN, with more than 50,000 customers and established Clean Traffic infrastructure connected to major domestic carriers, offers Blackwall the operational scale and market knowledge required for an effective regional entry.

Blackwall has indicated that Vietnam is the first in a planned series of Southeast Asia partnerships, with Indonesia, Malaysia and Thailand identified as subsequent target markets. The company has also announced a major Series B funding round to support its international expansion.

Availability

HOSTVN Website Protection — powered by Blackwall is available to HostVN customers effective 20 May 2026. Pricing is available through HostVN directly. Further information is available at hostvn.net and blackwall.com.

Hashtag: #Blackwall


The issuer is solely responsible for the content of this announcement.

About Blackwall

Blackwall is a web traffic security company headquartered in Tallinn, Estonia, specialising in web traffic management security for hosting providers, managed service providers and cloud infrastructure platforms. Blackwall’s all-in-one platform — combining load balancing, advanced bot mitigation, L7 DDoS protection, web application firewall (WAF), content caching, and SSL management — is delivered through a global network of hosting and infrastructure partners and protects more than 2.3 million websites worldwide. Blackwall.com

ABOUT HOSTVN (HOSTVN Technology Solutions Joint Stock Company)

HostVN has provided digital infrastructure services to Vietnamese businesses since 2007. The company operates shared hosting, VPS, dedicated servers, cloud infrastructure, and content delivery services, serving more than 50,000 customers. HostVN’s Clean Traffic infrastructure supports high-volume traffic management across major domestic carrier interconnects. Hostvn.net

Continue Reading

Media OutReach

AS Watson Launches brand lab to Turn Retail Scale into a Data-driven Brand Growth Engine

Published

on

HONG KONG SAR – Media OutReach Newswire – 22 June 2026 – AS Watson Group has launched AS Watson brand lab, a data-driven brand creation and scaling platform designed to systematically identify, develop, and grow brands across its global retail ecosystem. Built on the company’s integrated O+O (Offline plus Online) capabilities, extensive distribution network, and deep consumer insight from over 180 million loyalty members, the platform transforms how brands are brought to market – enabling both the creation of new propositions and the rapid scaling of brands across multiple markets with speed, discipline and consistency.

The initiative formalises capabilities the Group has been building internally, combining data-led demand identification, integrated distribution, and execution across more than 17,000 O+O stores in Asia and Europe.

Over the past two years, AS Watson has introduced more than 4,800 new brands and brand extensions across its network, underscoring the scale of its brand development activity.

From Incubation to Execution

AS Watson brand lab departs from traditional incubator models by embedding brand development directly within AS Watson’s retail ecosystem.

Rather than incubating brands ahead of their market entry, the platform operates inside the market, using real-time customer data, shopping behaviour and category dynamics to inform development decisions.

Dr Malina Ngai, Group CEO of AS Watson, said the model reflects the company’s structural advantage. “We don’t wait for brands to find the market – we build them where demand already exists, and scale them through our ecosystem.”

A Systemised Growth Model

At the core of AS Watson brand lab is an integrated operating model linking insight, creation, distribution, demand activation and scaling.

The platform leverages AS Watson’s over 180 million loyalty members and O+O capabilities to accelerate brand selection and commercial execution.

A Structured Pathway to Scale

Brands within AS Watson brand lab are supported through a structured growth pathway, progressing from early-stage validation to regional scaling and category leadership.

At each stage, brands receive differentiated support across insight, distribution, marketing activation and investment, ensuring resources are focused where the greatest growth potential exists.

This staged approach enables AS Watson to systematically build, scale and prioritise brands, improving success rates while maintaining disciplined capital allocation.

Focus on High-Growth Segments

AS Watson brand lab will prioritise product segments including Asian beauty trends (K-beauty, J-beauty, C-beauty), ingredient-led skincare, health and wellness products and elevated personal care – areas where consumer demand continues to evolve rapidly.

The Group expects the platform to strengthen its ability to build proprietary and exclusive brands while improving speed-to-market and capital efficiency.

Proven Brand Scaling in Action

Early outcomes demonstrate how AS Watson brand lab translates insight into accelerated growth – not only by shaping brand development, but by scaling brands rapidly across markets through its integrated O+O ecosystem.

Across multiple categories and geographies, the platform has enabled brands to move from targeted market entry to multi-market expansion with speed and discipline:

COSRX (K-Beauty)– By combining COSRX’s innovation-led skincare expertise with
AS Watson’s extensive retail footprint and deep consumer insights, the partnership has accelerated international expansion and broadened consumer reach. This illustrates how the platform converts strong brand propositions into sustained category growth across markets.

&honey (J-Beauty) – Leveraging its distinctive product positioning alongside
AS Watson’s regional scale, &honey rapidly expanded beyond its home market, rolling out across multiple Asian markets within a short timeframe. This demonstrates the platform’s ability to systematically scale proven domestic leaders into regional brands.

e.l.f. Cosmetics (US) – Through partnership with AS Watson, e.l.f. has extended its community-led, value-driven model across Europe, translating strong brand engagement into measurable market penetration. The example highlights how consumer-centric brands can be amplified through local market execution at scale.

essence (Germany) – The expansion of essence across multiple markets, including exclusive partnerships, reflects how purpose-driven brands can achieve consistency and reach when supported by integrated distribution and retail insight. This underscores the platform’s ability to build sustained brand relevance and loyalty across diverse markets.

Across these examples, brands have scaled through a consistent model – combining data-led selection, integrated distribution, and coordinated market execution – demonstrating how AS Watson brand lab functions as a repeatable engine for brand growth, from market entry through to regional scale.

Scaling a Repeatable Engine

AS Watson brand lab positions AS Watson to leverage its retail footprint not only as a distribution channel, but as an engine for brand creation and scaling.

The initiative signals a shift from opportunistic brand sourcing towards a structured, repeatable growth model, reinforcing AS Watson’s ability to scale brands with speed, discipline and consistency while driving long-term portfolio value.

AS Watson continues to engage with selected brand partners and emerging brands aligned with its focus areas, with further information available through its official
AS Watson brand lab platform (https://www.aswatson.com/asw-brand-lab)

Hashtag: #ASWatson

The issuer is solely responsible for the content of this announcement.

About AS Watson Group

Established in 1841, AS Watson Group is one of the world’s longest-standing and most recognised retail companies with roots in Asia. Today, the company operates over 17,000 stores across 12 retail brands in 31 markets, employing 130,000 people globally. This makes AS Watson Group the largest international health and beauty retailer in the world.

In the fiscal year 2025, AS Watson Group reported revenue of over US$26 billion. The company’s technology-enabled O+O (Offline plus Online) platforms serve over 6 billion shoppers annually, seamlessly integrating physical and digital retail experiences.

AS Watson Group supported over 180 charitable and non-profit organisations every year, dedicating over 40,000 hours of volunteer work to serve over 370,000 people in need in our operating markets.

AS Watson Group is also a member of the world-renowned multinational conglomerate CK Hutchison Holdings Limited, which has four core businesses – ports and related services, retail, infrastructure and telecommunications in over 50 countries.

Please visit for more information.

Continue Reading

Media OutReach

HKSTP Forges An Asia–Europe Innovation Gateway at VivaTech 2026

Published

on

A stream of partnership propose heightened tech and business connections across continents

HONG KONG / PARIS, FRANCE – Media OutReach Newswire – 22 June 2026 – Hong Kong Science and Technology Parks Corporation (HKSTP) has successfully concluded its Paris delegation to Viva Technology (VivaTech) 2026, which celebrated its 10th anniversary as a global stage for ambitious startups from June 17 to 20. HKSTP reinforces its impactful role as Asia’s I&T ecosystem orchestrator, by confirming the signing of multiple memorandums of understanding (MOU) between Park companies and the European I&T community:

  • Microalgae expert Algreen, signed with ForNatures, a South Korean Climate Tech company that specialises in carbon capture management, in amplifying mutual research and development capabilities to take a step closer to ESG goals.
  • Robotics solutions provider Robocore, signed with ARCHTYP, a Slovenian cognitive software startup, enabling the display of a differentiating layer on a proven platform to reach market demands, while also closing deals with French advertising guru JCDecaux, to supply a thousand robots and extend its reach in the European market.
  • The appeal and use cases of LeafIoT‘s green asset management has caught the eyes of European’s professionals in the preservation sector, including the French Agricultural Research Centre for International Development (CIRAD), the Catalonian landscaping and environmental restoration company Gremi de Jardineria de Catalunya, and notably, Professor Andrea Galli from the Laboratory of Geotechnical Analysis and Modelling (GeoT-LAM) at Politecnico di Milano, all taking solid steps in exploring new opportunities and breakthroughs and boosts in market reach.
An Asia-Europe innovation gateway forging forward at VivaTech 2026 with an influx of partnerships propose heightened tech and business connections across the world.

The annual showcase put a spotlight on enabling founders to connect with the local I&T community, explore market access, and forge global partnerships via pitching and matching sessions, networking mixers, and investor engagement. Compared with VivaTech 2025, this year’s delegation achieved even stronger momentum with over 50% growth in opportunities, totalling more than 200 potential business leads worth HK$70M in total.

HKSTP’s growing presence at VivaTech reflects its mission to open new doors for Hong Kong’s startups, build pathways into European markets and create reciprocal opportunities for European innovators to enter Asia through Hong Kong’s strategic location in the world’s No.1 innovation cluster – Guangdong-Hong Kong-Macao GBA (World Intellectual Property Organisation Innovation Index).

Terry Wong, CEO of HKSTP, said: “France and the EU represent critical opportunities for Hong Kong and Chinese Mainland I&T ventures to scale globally. VivaTech provides a world-class platform for collaboration, co-creation, and knowledge exchange. Our strong ties with French partners underline the importance of Hong Kong as a global launchpad for innovation, supporting startups on their journey from local success to international impact.”

Highlights this year include the expansion of HKSTP’s partnership with Bouygues Construction, a global leader in sustainable construction and infrastructure headquartered in France, and operates across more than 60 countries and is recognised for delivering major projects in transport, energy, real estate, and smart cities.

Through its Hong Kong arm, Dragages Hong Kong, Bouygues has maintained a 70-year legacy in Hong Kong, contributing to iconic infrastructure projects and championing innovation in areas such as construction safety, modular design, green materials, and site automation. HKSTP is the first and only institution in Hong Kong to bridge tech venture directly into the Bouygues Construction “Scale One: programme, providing a fast track to prototyping and commercialisation. This initiative sets a new benchmark for cross-border industrial innovation partnerships, accelerating global impact for Hong Kong startups through trusted collaborations with leading European enterprises.

Building on existing strong foundations, Bouygues Construction is now stepping up collaboration with HKSTP beyond Asia, offering selected Hong Kong startups the chance to showcase solutions at Bouygues’ headquarters in France, with opportunities for solution validation and pilot trials across European operations.

The Hong Kong Tech Pavilion, organised by the Hong Kong Trade Development Council (HKTDC) and supported by partners including HKSTP, showcased market-ready solutions spanning AI, green- and health tech from 24 tech ventures, and marked a major milestone in creating a direct bridge between Hong Kong and Europe’s heart of innovation and technology.
Hashtag: #HKSTP

The issuer is solely responsible for the content of this announcement.

HKSTP

More information about HKSTP is available at .

Continue Reading

Trending